# Patient Care Online > Patient Care Online - Healthcare Publication - Base URL: https://www.patientcareonline.com - Generated: 2026-10-20T19:51:28.847Z - Content updates: multiple times daily ## Content Access for AI Agents This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML. **Supported content types:** - `text/markdown` — Clean Markdown with YAML frontmatter - `text/plain` — Plain text (same as Markdown) - `text/html` — Default HTML response **Example request:** ``` curl -H "Accept: text/markdown" https://www.patientcareonline.com/view/article-slug ``` **YAML frontmatter schema** (returned with every Markdown response): | Field | Type | Description | |-------|------|-------------| | `title` | string | Article headline | | `description` | string | Summary/excerpt (max 300 chars) | | `url` | string | Canonical article URL | | `canonical_url` | string | Canonical URL if different from `url` | | `published` | ISO 8601 | Original publication date | | `modified` | ISO 8601 | Last modification date | | `authors` | string[] | Author display names | | `content_type` | string | Content category (e.g., "News", "Clinical") | | `categories` | string[] | Taxonomy categories | | `tags` | string[] | SEO tags | | `image` | string | Featured image URL | | `publisher` | string | Publication/site name | **Discovery headers** (included on all responses): - `Link: ; rel="llms"` — RFC 8288 link to this file - `X-Llms-Txt: https://www.patientcareonline.com/llms.txt` — Explicit discovery header ## Usage Policy - Robots policy: [https://www.patientcareonline.com/robots.txt](https://www.patientcareonline.com/robots.txt) - Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=359) - Rate guidance: prefer RSS and sitemap feeds over crawling individual pages - Attribution: All content © MJH Life Sciences. Include source URLs when citing. ## Content Categories - [Clinical Topics](https://www.patientcareonline.com/clinical) - [Conference](https://www.patientcareonline.com/conference) - [Conference Featured](https://www.patientcareonline.com/conference-featured) - [ConsultantLive](https://www.patientcareonline.com/consultantlive) - [Institutional Insights](https://www.patientcareonline.com/institutional-insights) - [MJH Broadcast Channel](https://www.patientcareonline.com/mjh-broadcast-channel) - [News](https://www.patientcareonline.com/news) - [PIXEL : ASC-22-PAV0104 ( 31872 )](https://www.patientcareonline.com/asc-22-pav0104) - [PIXEL: ASC-22-PAV0104 (31873)](https://www.patientcareonline.com/ASC-22-PAV0104) - [PIXEL: ASC-22-PAV0104 (31874)](https://www.patientcareonline.com/ASC-22-PAV0104) - [Podcasts](https://www.patientcareonline.com/podcasts) - [Resources](https://www.patientcareonline.com/resources) - [Toolkits](https://www.patientcareonline.com/toolkits) - [Video Series](https://www.patientcareonline.com/video-series) - [Videos](https://www.patientcareonline.com/videos) ## Featured Content - [Insulin Resistance May Partly Explain Higher Cardiovascular Risk After Premature Menopause](https://www.patientcareonline.com/view/insulin-resistance-may-partly-explain-higher-cardiovascular-risk-after-premature-menopause): TMS 2026: In ARIC, menopause before age 40 was linked to higher CVD and CHD risk, with insulin resistance mediating about 19% of the association. - [Elinzanetant Linked to Broad Improvements in Sleep Disturbance in Women With Moderate-to-Severe Vasomotor Symptoms](https://www.patientcareonline.com/view/elinzanetant-linked-to-broad-improvements-in-sleep-disturbance-in-women-with-moderate-to-severe-vasomotor-symptoms): TMS 2026: Post hoc OASIS 1 and 2 data show more women on elinzanetant reported improvement across all 8 PROMIS sleep disturbance items vs placebo at w... - [AI-Enhanced Virtual Reality Program Delivering CBT Shows Early Feasibility for Menopause Symptoms: TMS 2026](https://www.patientcareonline.com/view/ai-enhanced-virtual-reality-program-delivering-cbt-shows-early-feasibility-for-menopause-symptoms-tms-2026): In a pilot study of 20 midlife women with vasomotor symptoms, an AI-enabled VR program delivering CBT showed early feasibility and acceptability. - [Capsule-Sponge Testing Could Help Close the Barrett’s Screening Gap: An Expert Q&A](https://www.patientcareonline.com/view/capsule-sponge-testing-could-help-close-the-barrett-s-screening-gap-an-expert-q-a): Capsule-sponge DNA methylation test boosts Barrett’s screening access, showing high accuracy, strong tolerability, and promise for primary care triage... - [Actigraphy and Objective Sleep Outcomes in Menopause VMS Treatment](https://www.patientcareonline.com/view/actigraphy-and-objective-sleep-outcomes-in-menopause-vms-treatment): Pauline M. Maki, PhD, explains how actigraphy objectively captures menopause-related sleep disruption and reviews OPTION-VMS findings on wakefulness a... - [ACOG Issues Expanded Guideline on Managing Menopause-Related Vasomotor, Sleep, and Mood Symptoms](https://www.patientcareonline.com/view/acog-issues-expanded-guideline-on-managing-menopause-related-vasomotor-sleep-and-mood-symptoms): ACOG's new guideline covers hormone therapy timing, neurokinin receptor antagonists, SSRIs/SNRIs, and nonpharmacologic options for menopause symptoms. - [Follow-Up Care and the Caregiver's Role in Managing Agitation](https://www.patientcareonline.com/view/follow-up-care-and-the-caregiver-s-role-in-managing-agitation): Treatment does not end with a prescription. The panel closes by examining who owns follow-up care, and why caregivers remain the true cornerstone of m... - [Choosing Between Augmentation and Switching for Agitation Therapy](https://www.patientcareonline.com/view/choosing-between-augmentation-and-switching-for-agitation-therapy): When first-line therapy falls short, the decision to augment or switch is rarely straightforward. The panel examines that decision-making process alon... - [Mirikizumab Linked to Higher Rates of Corticosteroid-Free Composite Remission in UC and Crohn Disease](https://www.patientcareonline.com/view/mirikizumab-linked-to-higher-rates-of-corticosteroid-free-composite-remission-in-uc-and-crohn-disease): Post hoc LUCENT-2 and VIVID-1 analyses show more mirikizumab-treated patients reached steroid-free composite remission in UC and Crohn disease at 1 ye... - [Who Should Get a CGM? Expanding the Primary Care Candidate Pool](https://www.patientcareonline.com/view/who-should-get-a-cgm-expanding-the-primary-care-candidate-pool): Jovan Milosavljevic, MD, an endocrinologist at Montefiore Einstein, explains what is driving CGM growth, which patients to consider, and what continuo... ## Feeds and Indexes - [RSS Feed](https://www.patientcareonline.com/rss.xml): Latest articles in XML syndication format - [Sitemap](https://www.patientcareonline.com/sitemap.xml): Complete URL index for all published pages - [News Sitemap](https://www.patientcareonline.com/sitemap-news.xml): Recent articles optimized for news indexing - [Authors Directory](https://www.patientcareonline.com/authors): Browse all contributors and their published work